Role of circulating free Alu DNA in endometrial cancer

Hideo Tanaka, Hiroshi Tsuda, Sadako Nishimura, Hiroyuki Nomura, Fumio Kataoka, Tatsuyuki Chiyoda, Kyoko Tanaka, Yoko Iguchi, Nobuyuki Susumu, Daisuke Aoki

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

Background: Endometrial cancer (EC) is the most common cancer of the female genital tract. However, no screening method for EC has been established yet. In this study, we evaluated the cell-free DNA in EC. Methods: Fifteen healthy individuals, 9 with benign gynecologic diseases, and 53 with ECs were included in this study. Alu sequences in free DNA fragments were used as surrogate markers, and cell-free DNA density was measured by quantitative real-time polymerase chain reaction. Results: The cell-free DNA levels in ECs tended to be higher than in benign condition (healthy individuals + benign gynecologic diseases, n = 24; P = 0.095). There was no significant difference in cell-free DNA among stage or histological grade of EC, and no significant change in cell-free DNA before and after operation (P = 0.25): Moreover, in 19 ECs, cell-free DNA decreased after operation, however, in 6 ECs, cell-free DNA did not decrease. Three ECs recurred, and cell-free DNA did not decrease in these cases. Conclusions: Measurement of cell-free DNA is not useful for EC screening; however, the change of cell-free DNA in a patient may be a prognostic biomarker of EC.

Original languageEnglish
Pages (from-to)82-86
Number of pages5
JournalInternational Journal of Gynecological Cancer
Volume22
Issue number1
DOIs
Publication statusPublished - 2012 Jan

Fingerprint

Endometrial Neoplasms
DNA
Female Genital Diseases
Biomarkers
Early Detection of Cancer
Real-Time Polymerase Chain Reaction

Keywords

  • Endometrial cancer
  • Screening
  • Serum biomarker

ASJC Scopus subject areas

  • Obstetrics and Gynaecology
  • Oncology

Cite this

Role of circulating free Alu DNA in endometrial cancer. / Tanaka, Hideo; Tsuda, Hiroshi; Nishimura, Sadako; Nomura, Hiroyuki; Kataoka, Fumio; Chiyoda, Tatsuyuki; Tanaka, Kyoko; Iguchi, Yoko; Susumu, Nobuyuki; Aoki, Daisuke.

In: International Journal of Gynecological Cancer, Vol. 22, No. 1, 01.2012, p. 82-86.

Research output: Contribution to journalArticle

Tanaka, Hideo ; Tsuda, Hiroshi ; Nishimura, Sadako ; Nomura, Hiroyuki ; Kataoka, Fumio ; Chiyoda, Tatsuyuki ; Tanaka, Kyoko ; Iguchi, Yoko ; Susumu, Nobuyuki ; Aoki, Daisuke. / Role of circulating free Alu DNA in endometrial cancer. In: International Journal of Gynecological Cancer. 2012 ; Vol. 22, No. 1. pp. 82-86.
@article{74fbeddf70194b8293bebb8ba91ba3b6,
title = "Role of circulating free Alu DNA in endometrial cancer",
abstract = "Background: Endometrial cancer (EC) is the most common cancer of the female genital tract. However, no screening method for EC has been established yet. In this study, we evaluated the cell-free DNA in EC. Methods: Fifteen healthy individuals, 9 with benign gynecologic diseases, and 53 with ECs were included in this study. Alu sequences in free DNA fragments were used as surrogate markers, and cell-free DNA density was measured by quantitative real-time polymerase chain reaction. Results: The cell-free DNA levels in ECs tended to be higher than in benign condition (healthy individuals + benign gynecologic diseases, n = 24; P = 0.095). There was no significant difference in cell-free DNA among stage or histological grade of EC, and no significant change in cell-free DNA before and after operation (P = 0.25): Moreover, in 19 ECs, cell-free DNA decreased after operation, however, in 6 ECs, cell-free DNA did not decrease. Three ECs recurred, and cell-free DNA did not decrease in these cases. Conclusions: Measurement of cell-free DNA is not useful for EC screening; however, the change of cell-free DNA in a patient may be a prognostic biomarker of EC.",
keywords = "Endometrial cancer, Screening, Serum biomarker",
author = "Hideo Tanaka and Hiroshi Tsuda and Sadako Nishimura and Hiroyuki Nomura and Fumio Kataoka and Tatsuyuki Chiyoda and Kyoko Tanaka and Yoko Iguchi and Nobuyuki Susumu and Daisuke Aoki",
year = "2012",
month = "1",
doi = "10.1097/IGC.0b013e3182328c94",
language = "English",
volume = "22",
pages = "82--86",
journal = "International Journal of Gynecological Cancer",
issn = "1048-891X",
publisher = "Lippincott Williams and Wilkins",
number = "1",

}

TY - JOUR

T1 - Role of circulating free Alu DNA in endometrial cancer

AU - Tanaka, Hideo

AU - Tsuda, Hiroshi

AU - Nishimura, Sadako

AU - Nomura, Hiroyuki

AU - Kataoka, Fumio

AU - Chiyoda, Tatsuyuki

AU - Tanaka, Kyoko

AU - Iguchi, Yoko

AU - Susumu, Nobuyuki

AU - Aoki, Daisuke

PY - 2012/1

Y1 - 2012/1

N2 - Background: Endometrial cancer (EC) is the most common cancer of the female genital tract. However, no screening method for EC has been established yet. In this study, we evaluated the cell-free DNA in EC. Methods: Fifteen healthy individuals, 9 with benign gynecologic diseases, and 53 with ECs were included in this study. Alu sequences in free DNA fragments were used as surrogate markers, and cell-free DNA density was measured by quantitative real-time polymerase chain reaction. Results: The cell-free DNA levels in ECs tended to be higher than in benign condition (healthy individuals + benign gynecologic diseases, n = 24; P = 0.095). There was no significant difference in cell-free DNA among stage or histological grade of EC, and no significant change in cell-free DNA before and after operation (P = 0.25): Moreover, in 19 ECs, cell-free DNA decreased after operation, however, in 6 ECs, cell-free DNA did not decrease. Three ECs recurred, and cell-free DNA did not decrease in these cases. Conclusions: Measurement of cell-free DNA is not useful for EC screening; however, the change of cell-free DNA in a patient may be a prognostic biomarker of EC.

AB - Background: Endometrial cancer (EC) is the most common cancer of the female genital tract. However, no screening method for EC has been established yet. In this study, we evaluated the cell-free DNA in EC. Methods: Fifteen healthy individuals, 9 with benign gynecologic diseases, and 53 with ECs were included in this study. Alu sequences in free DNA fragments were used as surrogate markers, and cell-free DNA density was measured by quantitative real-time polymerase chain reaction. Results: The cell-free DNA levels in ECs tended to be higher than in benign condition (healthy individuals + benign gynecologic diseases, n = 24; P = 0.095). There was no significant difference in cell-free DNA among stage or histological grade of EC, and no significant change in cell-free DNA before and after operation (P = 0.25): Moreover, in 19 ECs, cell-free DNA decreased after operation, however, in 6 ECs, cell-free DNA did not decrease. Three ECs recurred, and cell-free DNA did not decrease in these cases. Conclusions: Measurement of cell-free DNA is not useful for EC screening; however, the change of cell-free DNA in a patient may be a prognostic biomarker of EC.

KW - Endometrial cancer

KW - Screening

KW - Serum biomarker

UR - http://www.scopus.com/inward/record.url?scp=84863294104&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84863294104&partnerID=8YFLogxK

U2 - 10.1097/IGC.0b013e3182328c94

DO - 10.1097/IGC.0b013e3182328c94

M3 - Article

C2 - 22146763

AN - SCOPUS:84863294104

VL - 22

SP - 82

EP - 86

JO - International Journal of Gynecological Cancer

JF - International Journal of Gynecological Cancer

SN - 1048-891X

IS - 1

ER -